#uty mr. screen | Explore Tumblr Posts and Blogs

faemoira-firebeard · 2 years

Text

"what if"

Soooo. I got stuck for a second... for a few days actually trying to figure out how my worlds story.... actually works. I've been watching random #DM and #GM videos on the youtubes, seriously such a plethora of info from lore to world building, map making to keeping it interesting. I really like this fellas channel, but for today heres a how to campaign build idea video https://www.youtube.com/watch?v=h1hXtlagnAA

My world's "what if" my huge plot twist... "there are NO humans here".... but, meta DM knowledge... there are humans, they've been mutated by the fey that put the stone-sleeping curse on them a few millenia ago when those baby tiktok witches tried some shit. They simply haven't come to the surface world, the deep elves, dwarves and gnomes haven't dug far enough, yet.... or have they? -evil laughter from behind the dm screen-

Cue my mad mage that lives "never"(north) of Frankenhollow. Frankenhollow is a mining town, most of it's population is made up of Goliaths, Dwarves and Gnomes; many of which favor the nature magics and other nature classes (druids, barbarians, rangers). They mine the cold iron from deep with in the Ice Rock Mountains....

Check out my map of Artezia (google drive, notes in the margin -chuckle- i still have a LOT of work to do)

I don't know why, but I decided the Mad Mage lives in a tower and is a pied piper that is herding cats to himself (for why? idk) my notes say "mr freeze" which I can only imagine means batman, Ah-nold... and notes say "deal with duergar - cold iron? weird magneto?" also more notes... winchester mystery house but it's a tower-labrynth-tardis-biggerontheinside- ok... dude fae, what the fuck is in your head.

ok ok ok... soooo i can somehow spiderweb all of that together to bring in the "WHOA SHIT!!! huuu-mannnns- moment." cuz BAM I bring you to Frankenhollow.

Each year on the harvest double-new moon the people of Frankenhollow make an offering to Funilla Utis, the Bringer of Ice. The white dragon protects the town so long as the offering is substantial enough They spend their time feeding on the yetis and other creatures that live in the peaks and valleys of the Ice Rock Mountains. No one in Frankenhollow has actually seen Lord of the White Skies since it was a young adult. This is where my gremlins (i mean children) and their siblings campaign comes in. -which is in a completely different notebook, either on my desk or possibly under my couch... but I hurt really bad today after pretty hard fall while scooting around town. I shall post more when I'm able to move and sit comfortably.

peace out side! -fae

ps, snow + e-scooter = failed wisdom check (shoulda known better)

#d&d #dungeons and dragons #dnd #artezia #dnd worldbuilding #dnd 5e #dnd campaign #dnd stuff #homebrew #dnd5e #d&d stuff #d&d worldbuilding #d&d 3.5 #d&d 5th edition #d&d campaign #dnd homebrew

0 notes

scamperingscribbles · 6 years

Text

Melonhead

It was Wednesday again, and Emil’s presentation wasn’t perfect yet, so it might as well have been armageddon. He sat in his cubicle, twitching nervously at his desk as the three cups of black coffee he’d downed in the last hour wound their way through his bloodstream. Perfection was non-negotiable, especially two weeks into his new position of reporting directly to the highest manager, with last week’s meeting in the books as a complete catastrophe. All he’d had to do was go over how the latest product they’d released had been selling over the past month. A simple statistic, and a simple presentation. He should have been able to get through it without a single screw up. He’d done it plenty of times before.

Instead, he’d completely frozen before he’d even turned on the projector, because Mr. Maloney had come in, taken one look at Emil’s outfit, and then decided to make an off-handed comment to a lower-division manager about the tackiness and unprofessionalism of the paisley pattern in ties. It had gone downhill from there. Emil had made an attempt to scratch his nose while answering a simple question about gross profits, and had instead spilled his entire cup of scalding black coffee down the front of his blazer. Today, with fifteen minutes left before his presentation, Emil was quickly coming to realize that it was pretty difficult to type with his head buried in his hands.

“Maria?” said a voice. “What are you doing here?”

Emil blinked through his fingers and looked up at the ceiling. Had that voice come through the loudspeaker, or was he imagining things? He wasn’t sure. Not that he wouldn’t have liked it if he’d really heard something; he’d be glad for any excuse to take his mind on a nice date to literally anywhere else.

“James Matthew Maloney, I need to talk to you.”

“I see that. You are, in fact, talking to me, Maria.”

“No, but not— I mean, talk.”

“There’s a difference between talking and talking?”

“That’s not— you’re missing the point!”

“What point? The only point you’ve made is that we’re not talking until we’re talking, and if we’re not talking yet, then I’d say that no point has really been made.”

“I—you— will you fucking stop that?”

Frozen in his desk chair, Emil was now positive that he was not imagining things. Someone in the main office must have accidentally turned on the intercom, because Maloney’s voice was now crackling through the air, accompanied by a woman’s voice that Emil didn’t recognize. He stared at his screen unseeing, not daring to move.

“Was there something you wanted to discuss?”

“Yes, James, there is something I wanted to discuss.”

“Come on, there’s no need to take that tone—”

“Oh, there isn’t? Remind me who you are to tell me what tones I can and cannot take, hmm?”

“Maria, please—“

“Don’t ‘Maria’ me!”

Emil suddenly became aware he was not the only one eavesdropping. The office had gone completely silent; clicks of keyboards, shuffles of paper, occasional bouts of cursing over spilled mugs of cold coffee— all gone. He wondered, in spite of himself, where all this rapt attention was during his presentation last week.

“Then what’s the problem? Make it fast, if you could— you’ve decided to barge into my office in the middle of my day, and I have a meeting to attend in fifteen minutes.”

“Oh my god, you’re such an ass.”

“What the hell did I do now?”

“The cantaloupe that I brought home literally yesterday, that’s what you did.”

Emil had never been aware that silence could change tone, but apparently it could, and it did. It morphed, somehow, from a quiet tension into that characteristic silence that occurs immediately after someone farts loudly in a silent auditorium. A sort of shocked, incredulous silence. A few cubicles over, somebody coughed.

“Alright, now hold on just a second here—”

“James!”

“Would you calm down? The employees will hear you.”

“Maybe they should! Maybe I want them to! Maybe I want them to know exactly what my idiot of a husband does to the fresh produce I bring home for our weekend brunch with his parents!”

A snicker rippled through the cubicles, reminding Emil distinctly of the familiar sound that used to accompany falling on one’s face in high school gym class. He cracked a smile. This was the most fun he’d had since his striped tie had gotten stuck in the fax machine. It had been a really terrible tie.

“Maria, please—“

“I told you last night that I was saving it for them, and this morning I come into the kitchen and find it full of holes!”

“You were asleep— and I couldn’t just leave for work like that, I had to do something, and it was right there—”

“The fuck is wrong with using your hands, James?”

Emil’s ribs were killing him. He could hear the snickers from the cubicles getting louder, with occasional subdued snorts— he clapped his hand over his mouth to keep from laughing, the sudden movement tipping a stack of meticulously organized notecards onto the floor. He paused— for once, he realized, literally nothing in his life mattered any less than picking them back up and putting them back in order. They could lie there at his feet for hours, for all he cared. Maybe he hadn’t even needed them in the first place. He tentatively stepped on one, and it crumpled under his polished black shoe. Beneath his hand, he slowly began to grin.

“I’m sorry, I wasn’t thinking straight, I was in a rush, it was right there— Maria, I’m sorry, but can we please talk about this later? At home? When I’m not at work, or in public?”

“Oh, of course, now he apologizes. Now he feels sorry. He’s gonna feel a hell of a lot sorrier when he ends up with a UTI from a melon, I can tell you that much.”

“I used protection, Maria, I’m not an idiot.”

“Oh? Oh, you used protection, now, did you? Tell me, did you use one of the ribbed ones, for the cantaloupe’s personal pleasure? I mean, lord knows you’d need the boost—”

“Maria!”

Now hunched over his keyboard in silent spasms of suppressed snickering, Emil came to the conclusion that he had not previously been aware of what true pain was, regardless of circumstance. His ribs felt like they were about to burst, he’d never wanted to laugh so badly in his life. The woman in the next cubicle had already excused herself to the restroom in a fit of giggles; Emil didn’t dare follow suit. He didn’t want to miss a goddamn second of this. This was gospel. Sadistic, awful, beautiful gospel.

“Look, I just want to know if you asked for its consent first, because you certainly didn’t ask for mine on the subject— not that I would’ve given it to you, but I’m not the cantaloupe, now, am I?”

“This is getting ridiculous.”

“More ridiculous than my finding our brunch cantaloupe leaking in the sink?”

Someone must have fallen over in muffled hysterics on top of the copy machine, based on the distressed beeping and giggles now eminating from the back of the office. Emil couldn’t blame them in the slightest. He stuffed his pale pink tie into his mouth, hoping it would quiet the odd squeaking noises he was now making. Evidently, Marshalls didn’t product-test their ties for flavor; it tasted like dust. And suppression. And also paisley patterned cloth, he realized, with just a tiny thrill of devilish glee.

“Maria, please, this really isn’t the time or the place to be talking about this.”

“When would you like to, then?”

“Later. At home. Like I said.”

“What if I threw the rest of the cantaloupe at your other head when you walked through the door, would that be a good conversation starter? Since that head is supposed to have a brain in it?”

“...I think we’re finished here.”

“Don’t you push me— James, we are not finished here! James—!“

“Please, Maria, go home. We will talk about this when I get back this evening, alright? I swear.”

“This conversation is not over.”

“Of course not, dearest heart. Now, would you please—?”

The door of the corner office opened, and then slammed loudly. Livid, high-heeled footsteps stormed past Emil’s cubicle and towards the elevator; he spat out his tie and tried fruitlessly to cease his spasms by thumping his fist on his thigh a few times. The sound of the corner office door opening again caught his attention, and he froze.

Black rubber soles he had once thought he feared tapped across the floor toward his cubicle. A slightly flushed face poked through the open wall, stiffly adjusting the pristine scarlet tie on its neck and furrowing its eyebrows. He turned toward it, quickly attempting to plaster on a neutral expression.

“Emil?”

“Yes, Mr. Maloney?” He thought he saw the face loosen at his respectfulness, if only slightly.

“You’re ready for our meeting?”

“Yes, Mr. Maloney.”

“We’re in room 216 again, I assume?” The expression was definitely calmer now, more confident; his nose began to lift with an air of superiority Emil had seen all too often.

“Yes, Mr. Maloney.”

“Good. Don’t be late.” He threw his shoulders back, his chest thrusted forward, composure regained along with supposed control. Emil coughed.

“Never, Mr. Maloney.”

“You may want to leave your mug of coffee in your cubicle, this time.” The face contorted into a sneer, lowering its eyebrows, searing Emil with an accusatory glare.

“Of course, Mr. Maloney.”

“Right.”

The head withdrew from the wall again, and the footsteps tapped away. Emil blinked at his crumpled notecards on the floor, and then returned his gaze to the space where the head had been. For months, even before he’d been reporting to Maloney directly, he’d allowed himself to be crushed under rubber-soled heels that he had deemed judge, jury, and executioner. Why was he only now coming to the simple conclusion that he disliked being stepped on?

He stood slowly from his chair and turned toward the hallway; the apprehensive silence followed his footsteps as he walked towards the meeting room. Placing his hand on the door handle, he paused. He heard himself speak, his words cutting smoothly through the deafening hush.

“Anything for you, Mr. Melonhead, sir.”

If there was any sound in the world more beautiful than that of an entire office exploding into peals of wheezing, unbridled laughter, Emil didn’t want to know what it was.

#creative writing #short story #humor #melonhead #reupload- now with edits!

3 notes · View notes

eleostheofilusg · 4 years

Photo

Skills & Endorsements 26/50 (Corporate Events 29/99+) . . . The Top 7 Types of Corporate Events . . . When looking for new ways to engage employees, corporate event professionals experiment with multiple event formats. From fun incentive trips to spectacular galas, you can align the goals of an organisation with a huge variety of corporate meeting types. . 1. Trade shows . Goals: Generate leads and establish partnerships . Costs: $20,000–$40,000 . Secret of success: Ensure your booth stands out by making use of strategic lighting, multi-screen displays, lucrative promotional offers, etc. . 2. Appreciation events . Goals: Depending on the target audience, appreciation events can aim to recognise employees’ achievements or to build tight connections with loyal clients. . Costs: $5,000–$20,000 . Secret of success: Provide a relaxing atmosphere, friendly environment, capabilities for networking, and valued prizes. . 3. Holiday parties . Goal: Create a holiday mood . Costs: $1,000–$20,000 . Secret of success: Creativity should be your one and only ally here. . 4. Product launches . Goals: Raise awareness about a new product or service or acquire clients. . Costs: $1,000–$100,000 . Secret of success: The primary focus should be placed on gaining media exposure. . 5. Business dinners . Goals: Celebrate milestones, welcome a new employee, etc. . Costs: $200–$5,000 . Secret of success: Have a perfect understanding of your team members’ interests and preferences. . 6. Conferences . Goals: Gather targeted audiences in one place to share ideas, implement solutions, or improve collective expertise . Costs: $30,000–$1,500,000 . Secret of success: Thorough planning and a focus on technology investment are crucial. . 7. Incentive trips . Goals: Entertain and reward staff or maintain a business’s good reputation . Costs: $30,000–$2,000,000 . Secret of success: Sharp negotiation skills . . . For those of you who are working as Corporate Event Organizer, what are your thoughts on Corporate Events? Has it been easy or difficult to held Corporate Events? . https://linktr.ee/eleostheofilusg . Mr. "ET" Eleos Theofilus Gandawidjaja, S.Pd . https://linktr.ee/darwinandassociates . #ET (at UTI Lumpia) https://www.instagram.com/p/B_cM1Y1Fr9Z/?igshid=b4mz75j32o1o

#et

0 notes

brettecrowca · 4 years

Text

Clinical Evaluations in Boynton Beach, FL - Freedom Now Clinic

Table of ContentsWhat Is Clinical And Radiographic DiagnosisHow Is The Clinical Diagnosis Of A Uti EstablishedWhat Is Diagnosis In Clinical PsychologyDual Diagnosis Is A Clinical Diagnosis That Is Used When A Person Is Addicted To More Than One DrugWhat Type Of Results Are To Be Expected Based On A Diagnosis Confirming Clinical Data?What Is The Clinical Diagnosis Of AlchoholsmWhich Of The Following Pairs Must Be Present For The Clinical Diagnosis Of Pps?What Clinical Diagnosis Would You Utilize In ShinglesWhat Does Clinical Diagnosis MeanHow To Write Clinical Diagnosis

Hippocrates was known to make medical diagnoses by tasting his clients' urine and smelling their sweat. Medical medical diagnosis or the actual procedure of making a diagnosis is a cognitive process. A clinician utilizes a number of sources of data and puts the pieces of the puzzle together to make a diagnostic impression. The preliminary diagnostic impression can be a broad term explaining a classification of diseases instead of a specific illness or condition.

Diagnostic procedures are the specific tools that the clinicians utilize to narrow the diagnostic possibilities. The plural of medical diagnosis is diagnoses. The verb is to identify, and a person who diagnoses is called a diagnostician. The word is derived through Latin from the Greek word (dignsis) from (diagignskein), suggesting "to discern, identify".

How To Write Clinical Diagnosis For Dsm 5 And Icd 10

It might be a matter of calling the illness, lesion, dysfunction or impairment. It may be a management-naming or prognosis-naming exercise. It might indicate either degree of problem on a continuum or type of irregularity in a category. It's affected by non-medical aspects such as power, ethics and monetary rewards for client or doctor.

It may be a method of communication such as a computer system code through which it triggers payment, prescription, notification, information or advice. It may be pathogenic or salutogenic. It's normally unpredictable and provisional. When a diagnostic viewpoint has been reached, the service provider has the ability to propose a management strategy, which will include treatment in addition to plans for follow-up.

Which Of The Following Is A Problem With Using Unstructured Clinical Interviews In Diagnosis?

A treatment strategy is proposed which might include therapy and follow-up consultations and tests to keep track of the condition and the progress of the treatment, if required, usually according to the medical guidelines provided by the medical field on the treatment of the particular illness. what clinical assessment data supports the diagnosis of arf for mrs. hayes. Pertinent info should be contributed to the medical record of the patient.

Nancy McWilliams identifies 5 factors that determine the requirement for medical diagnosis: diagnosis for treatment planning; info included in it related to prognosis; protecting interests of patients; a medical diagnosis may help the therapist to empathize with his client; might decrease the probability that some afraid clients will go-by the treatment. Sub-types of medical diagnoses consist of: Scientific medical diagnosis A medical diagnosis made on the basis of medical indications and reported signs, instead of diagnostic tests Laboratory medical diagnosis A diagnosis based considerably on lab reports or test results, instead of the physical exam of the client.

What Is A Clinical Diagnosis

Radiology diagnosis A diagnosis based mainly on the results from medical imaging studies. Greenstick fractures prevail radiological diagnoses. Tissue medical diagnosis A diagnosis based upon the macroscopic, microscopic, and molecular assessment of tissues such as biopsies or entire organs. For instance, a conclusive medical diagnosis of cancer is made through tissue examination by a pathologist.

Many clients have extra diagnoses. Admitting diagnosis The diagnosis given as the reason the patient was confessed to the health center; it may vary from the actual issue or from the discharge diagnoses, which are the medical diagnoses taped when the client is discharged from the health center. A procedure of determining all of the possible diagnoses that might be connected to the signs, symptoms, and laboratory findings, and then ruling out medical diagnoses up until a last decision can be made.

What Is The Definition Of Clinical Diagnosis

They are standards, usually released by worldwide committees, and they are developed to provide the very best sensitivity and uniqueness possible, respect the existence of a condition, with the advanced technology. Medical diagnosis work done before birth A medical condition whose presence can not be developed with total self-confidence from history, examination or screening.

The medical diagnosis of two related, however different, medical conditions or co-morbidities. The term often described a diagnosis of a severe mental illness and a compound dependency, nevertheless, the increasing occurrence of hereditary testing has actually revealed lots of cases of patients with several concomitant congenital diseases. The medical diagnosis or recognition of a medical conditions in oneself.

How Does A Clinical Psychologist Diagnosis

What Is A Clinical Diagnosis

A type of telemedicine that diagnoses a client without being physically in the same space as the patient. Rather than focusing on biological procedures, a nursing diagnosis recognizes individuals's reactions to situations in their lives, such as a preparedness to alter or a determination to accept assistance. Supplying signs enables the computer system to recognize the issue and detect the user to the very best of its ability.

The medical diagnosis of "illness" that will never ever trigger symptoms, distress, or death throughout a client's lifetime An unclear, or even completely phony, medical or psychiatric label offered to the patient or to the medical records department for essentially non-medical reasons, such as to assure the client by supplying an official-sounding label, to make the supplier appearance efficient, or to obtain approval for treatment.

What Is A Clinical Diagnosis

The labeling of a disease in a historic figure or particular historic occasion utilizing contemporary knowledge, approaches and disease categories. See for variants. Thompson, C. & Dowding, C. (2009) Essential Decision Making and Medical Judgement for Nurses. "Making a medical diagnosis", John P. Langlois, Chapter 10 in Principles of clinical practice (2002 ).

Mengel, Warren Lee Holleman, Scott A - what is clinical diagnosis. Fields. Second edition. p. 198. "Making a diagnosis", John P. Langlois, Chapter 10 in Fundamentals of medical practice (2002 ). Mark B. Mengel, Warren Lee Holleman, Scott A. Fields. 2nd edition. p. 204. Wadhwa, R. R.; Park, D. Y.; Natowicz, M. R. (2018 ). "The precision of computerbased diagnostic tools for the recognition of concurrent congenital diseases".

Which Clinical Manifestations Support A Diagnosis Of Hyperglycemia? Select All That Apply.

176 (12 ): 270409. doi:10.1002/ ajmg.a. 40651. PMID 30475443. Decision support group. 26 July 2005. 17 Feb. 2009 "workup". The Free Dictionary. Damestani , Yasaman( 2013 ). "Transparent nanocrystalline yttria-stabilized-zirconia calvarium prosthesis". Nanomedicine. Elsevier Inc. 9( 8): 113538. doi:10.1016/ j.nano. 2013.08.002. PMID 23969102. Discussed by Mohan, Geoffrey( September 4, 2013). "A window to the brain? It's here, states UC Riverside team". "Diagnostic errors are leading cause of effective.

malpractice claims ". The Washington Post. 2012-04-30. Obtained 2016-10-31. "What is overdiagnosis?". NCBI. Coon, Eric; Moyer , Virginia; Schroeder, Alan; Quinonez, Ricardo." Overdiagnosis: How Our Obsession for Diagnosis May Be Harming Kid". AAP News and Journals Gateway. Gawande, Atul." America's Upsurge of Unnecessary Care ". The New Yorker. Improving Diagnosis in Health Care. Washington, DC: The National Academies Press. p. S-1. doi:10.17226/ 21794. ISBN 978-0-309-37769-0. PMID 26803862. CS1 maint: multiple names: authors list( link) Johnson, P. E. ; Duran, A. S.; Hassebrock, F.; Moller, J.; Prietula, M.; Feltovich, P. J.; Swanson, D. B.( 1981). "Expertise and Mistake in Diagnostic Reasoning". Cognitive Science. doi:10.1207/ s15516709cog0503_3. Chan, K. W.; Felson, D. T.; Yood, R. A.; Walker, A. M. (1994).

How Does A Clinical Psychologist Diagnosis

" The lag time between onset of signs and medical diagnosis of rheumatoid arthritis ". Arthritis and Rheumatism. 37 (6 ): 81420. doi:10.1002/ art. 1780370606. PMID 8003053. Workplace of Health and Human Solutions: Workplace of Inspector General (1993 ). " Medicare's Reimbursement for Interpretations of Medical Facility Emergency Clinic X-Rays "( PDF)." Edwin Smith Papyrus". Retrieved 2015-02-28. H. F. J. Horstmanshoff, Marten Stol, Cornelis Tilburg( 2004), Magic and Rationality in Ancient Near Eastern and Graeco-Roman.

Medicine, pp. 9798, Brill Publishers, 90-04-13666-5. Jingfeng, C.( 2008 )." Medication in China". Encyclopaedia of the History of Science, Technology, and Medicine in Non-Western Cultures. pp. 152934. doi:10.1007/ 978-1-4020-4425-0_8500. "What Would Hipocrates Do?". Retrieved February 28, 2015." Online Etymology Dictionary". Treasure, Wilfrid (2011). " Chapter1: Medical diagnosis". Diagnosis and Threat Management in Medical care: words that count, numbers that speak. Oxford: Radcliffe. ISBN 978-1-84619-477-1. McWilliams, Nancy( 2011). Psychoanalytic Diagnosis. Guilford. p. 8. ISBN 978-1-60918-494-0." confessing medical diagnosis". The Free Dictionary . Berner, E. D.; Shugerman, A.A.; et al." Performance of 4 computer-based diagnostic systems". New England Journal of Medication. 330( 25): 179296. doi:10.1056/ NEJM199406233302506.

Where Can I Get Clinical Cases And Diagnosis

youtube

WebMed Solutions. "Connection between start of signs and medical diagnosis". Archived from the original on 13 February 2019. Recovered 15 January 2012. It's especially essential to talk to a GP if you: In some cases, when you're depressed it can be difficult to picture that treatment can really assist. But the quicker you look for treatment, the sooner your anxiety will enhance (describe the goals of clinical assessment and diagnosis. explain how these goals affect treatment.). There are no physical tests for depression, but a GP may examine you and perform some urine or blood tests to eliminate other conditions that have comparable symptoms, such as an underactive thyroid. Try to be as open and truthful as you can be with your responses. Describing your signs and how they're affecting you will assist the GP figure out whether you have anxiety and how serious it is . Any conversation you have with.

a GP will be confidential. This rule will just ever be broken if there's a considerable danger of harm to either yourself or others, and if notifying a member of the family or carer would reduce that danger.

Freedom Now Clinic

236 SE 23rd Ave, Boynton Beach, FL 33435

GW4P+R9 Boynton Beach, Florida

https://myfreedomnow.com/

https://myfreedomnow.com/medical-clinical-evaluations/

Clinical Evaluations in Boynton Beach, FL

Find Freedom Now on Google Maps!

Videos:

https://youtu.be/dkSw1tLNN78

https://vimeo.com/451581551

Further Information:

https://freedomnowclinic.blogspot.com/2020/08/clinical-evaluations-in-boynton-beach.html

from Freedom Now Clinic https://freedomnowclinic.blogspot.com/2020/08/clinical-evaluations-in-boynton-beach.html

0 notes

marketinsightsstuff · 4 years

Text

UTI (Urinary Tract Infection) Treatment Market to reach US$ 9 Mn by 2029

The increasing prevalence of urinary tract infection (UTI) and growth in the number of prescription of quinolones antibiotics is expected to fuel the growth of the urinary tract infection treatment market. According to a new study published by Future Market Insights (FMI), the global urinary tract infection treatment market revenues will grow at a mere 2% CAGR between 2019 and 2029.

Launch of New Antibiotics for Bacterial Infections to Sustain Revenues

Increase in the number of research and development initiatives for the developing novel therapeutics has led to the launch of new drugs into the urinary tract infection treatment market. Manufacturers are currently focusing on expanding their pipeline portfolio for the treatment of bacterial infections. Moreover, regulatory bodies such as FDA have accelerated the approval process of drugs.

Recently, in August 2018, Melinta Therapeutics announced the launch of Vabomere (meropenem and vaborbactam) for patients who require treatment for complicated urinary tract infection. Similarly, one more drug has been approved by FDA in June 2018, Zemdri by Achaogen, Inc., for the treatment of adults suffering from Complicated Urinary Tract Infection (cUTI). Increase in the launch and approval of novel therapeutics for the treatment of bacterial infections is expected to contribute to the growth of the urinary tract infection treatment market.

Quinolones, the broad spectrum antibiotics effective against a wide range of bacterial disease, have bactericidal activity that enables them to penetrate deep into the tissue. Their excellent bioavailability is a plus point. In addition, they have favourable tolerability and safety profile. Moreover, they have significant antimicrobial activity. Thus, quinolones are most preferred for the treatment of urinary tract infection. Some of the widely used quinolones for the prevention of bacterial infection include ciprofloxacin (Cipro), ofloxacin (Floxin), norfloxacin (Noroxin), and others. Quinolones are mostly favored over trimethoprim-sulfamethoxazole (TMP-SMX) for the treatment of uncomplicated urinary tract infections owing to the increasing resistance of bacteria towards antibiotics such as trimethoprim-sulfamethoxazole, beta lactam antibiotics, and others.

Europe Remains Major Revenue Contributor

Europe holds a considerable revenue share in the UTI treatment market. The rising prevalence of urinary tract infection among the population and increasing hospital visits are among factors that are likely to propel the growth of the urinary tract infection treatment market. It is estimated that the urinary tract infection treatment market will create an incremental $ opportunity worth nearly US$ 9 Mn between 2019 and 2029. Quinolones is anticipated to boost the growth of the urinary tract infection treatment market owing to the increasing prescription and high effectivity as antimicrobial antibiotics.

Demand from Retail Pharmacies to Register High Growth

The global urinary tract infection treatment market has been segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the urinary tract infection treatment market has been segmented into Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides (Sulfamethoxazole +Trimethoprim), Azoles and Amphotericin B, Tetracycline (Doxycycline), Nitrofurans (Nitrofurantoin), and others. In terms of revenue, the quinolones segment is expected to hold a major share of the urinary tract infection treatment market during the forecast period since it is widely prescribed and has proven to be safe and effective for antimicrobial use.

Based on indication, the urinary tract infection treatment market has been segmented into complicated urinary tract infection and uncomplicated urinary tract infection. On the basis of distribution channel, the urinary tract infection treatment market has been categorised into hospital pharmacies, gynaecology & urology clinics, drug stores, retail pharmacies, and online drug stores. The retail pharmacies segment is expected to exhibit high revenue growth in the urinary tract infection treatment market owing to the easy availability of antibiotics.

Key Companies in Urinary Tract Infection Treatment Market

The report studies some of the key companies operating in the urinary tract infection treatment market, such as Bayer AG, GlaxoSmithKline Pharmaceuticals Ltd., Pfizer, Allergan Plc, Almirall SA, Bristol-Myers Squibb, and Merck & Co., Inc. For more insights on the competitive landscape and other facets shaping the growth of UTI treatment market.

Press Release Source: https://www.prnewswire.com/news-releases/urinary-tract-infection-treatment-market-in-a-slump-revenues-poised-for-2-cagr-over-2019-2029--future-market-insights-300876019.html

More from FMI’s Healthcare, Pharmaceuticals and Medical devices Market Intelligence:

· Memory Enhancing Drugs Market

· Home Sleep Screening Devices Market

· Fluorescence Spectroscopy Market

Request for covid19 Impact Analysis: https://www.futuremarketinsights.com/covid19/rep-gb-1340

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s largest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: [email protected]

For Media Enquiries: [email protected]

Future Market Insights

0 notes

alwayssweatycolor · 4 years

Text

Stool Management Systems Market Opportunities, Top Key Players and Forecast to 2029 | FMI

VALLEY COTTAGE, N.Y. (GLOBE NEWSWIRE) -- The global sales of stool management systems reached ~ US$ 355 million in 2018, unveils the new research study by Future Market Insight (FMI). According to the report, the stool management systems market is estimated to grow at a CAGR of ~ 3% in 2019, primarily influenced by the rising levels of awareness about incontinence. The increasing focus on awareness about incontinence offers sustainable growth opportunity for the stool management systems market throughout 2029, says the report.

The market for stool management systems in North America and Europe seems almost equivalent in terms of production in 2018. However, there are chances that this scenario will change during the forecast period. The European market is expected to take the lead in global stool management systems market, which FMI’s report has attributed to the increasing number of manufacturers within the European region, with diverse product offerings.

1.2X Demand Growth Projected for Pediatric Stool Management Systems

While the demand for stool management systems for adults continues to hold the larger share, pediatric stool management systems are also expected to grow at a significant rate. Increasing attention towards pediatric fecal incontinence is further expected to boost the market growth during the forecast period.

Among different age groups, the adults segment for stool management systems is projected to take the leading position in the market. However, owing to rising problems of pediatric fecal incontinence and growing awareness among people, pediatric stool management systems is expected to grow 1.2X by the end of 2029. Furthermore, the adult stool management systems market is likely to face hindrance in growth due to high number of cases unreported such as social stigma about the disease.

Fecal incontinence is a common problem observed in children with spina bifida and anorectal malformations. Globally, it is noted that ~200,000 babies are born with spina bifida and bowel dysfunction and ~8,500 babies born with anorectal malformation and fecal incontinence.

These pediatric bowel dysfunctions can be effectively managed with a well-established bowel management training programs. However, the bowel management training programs currently focuses on the adult and aging population mainly. Growing awareness regarding the pediatric fecal incontinence is likely to emphasize specialized training programs for bowel management of paediatric patients.

Cost-Effectiveness of Fecal Management Systems to Ensure Economic Benefits

Fecal incontinence is a common condition that impacts the life of patients with an economic burden in hospitals. The usage of stool management systems in hospitals has contributed significant economic benefits to the society and health benefits to patients. The total cost associated with stool management systems is lower than the traditional management system when factors such as urinary tract infections (UTI) cost, labor cost, indirect costs, and total product related costs are taken into consideration.

For instance, a study conducted in Canada reported a decrease from 35% to 42% in the daily material costs after the usage of stool management systems as compared to the traditional methods of using bedpans, briefs, and linens for the treatment of fecal incontinence. According to the study, the average daily material cost per patient ranged between CA$100 - CA$140 with traditional management system. However, this cost reduced to over CA$60 - CA$90 with the usage of stool management systems.

Furthermore, the usage of stool management systems in patients with fecal incontinence enables the prevention of pressure ulcers, which is one of the common complications in such patients.

Press Release Source: https://www.globenewswire.com/news-release/2019/10/07/1925813/0/en/Stool-Management-Systems-Market-is-anticipated-to-grow-at-a-CAGR-of-3-during-the-forecast-period-2019-to-2029-Future-Market-Insights.html

Related Press Release:

Cotinine Screening Devices Market is expected to grow at a CAGR of ~5% in the forecast period 2019 to 2029

Pressure Infusion Bags Market is expected to grow at a CAGR of ~6% during 2019 to 2029

Organoids Market is projected to grow at a Significant CAGR of ~ 15% during 2019 to 2029

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Mr. Abhishek Budholiya Future Market Insights 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44 (0) 20 7692 8790 Sales: [email protected] Press Office: [email protected]

#Stool Management Systems Market

0 notes

techsciresearch · 3 years

Text

Organ-on-Chip Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research

Increasing renal disease is driving the growth in Global Organ-on-chip Market in the forecast period, 2022-2026.

According to TechSci Research report, “Organ-on-Chip Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Type (Liver, Heart, Lung, Kidney, Others), By Offering (Products v/s Services), By Material Type (Polymer, PDMS, Glass, Silicon, Others), By Application (Physiological Model Development, Drug Discovery, Toxicological Research, Molecular Biology, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cosmetic Industry, Others), By Region”, the global organ-on-chip market would potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of rapidly evolving healthcare industry in major economies as well as developing nations. Recent pandemic caused a high alert for the healthcare industry to expand, research and evolve and thus the major driving factor for the global organ-on-chip market in the upcoming five years.

Organ-on-chip is a technologically advanced medical device that in layman’s term beneficial for the treatment of the failing or ruptured organs of the human body. This is a microfluidic cell culture device that is developed to contain continuously perfused chambers inhabited by living cells arranged to simulate tissue- and organ-level physiology. Microchip manufacturing methods are used to develop these chips. A narrow channel is developed such that blood and air flow in organs like lung, liver, heart, kidney, gut, etc. can be maintained. The organ-on-chip devices produce multiple level of cells that perform the functionalities of the tissues or organ physiology. Applications of these devices involve diseases modelling, patient stratification, and phenotypic screening.

Moreover, rising demand for the drug toxicity in the human cells after consumption is driving the growth of the global organ-on-chip market. Government funding, private investments are further substantiating the growth of the global organ-on-chip market in the future five years.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Organ-on-chip Market"

https://www.techsciresearch.com/report/organ-on-chip-market/7763.html

The global organ-on-chip market is segmented by type, offering, material type, application, end user, competitional landscape, and regional distribution. Based on offering, the market is further segmented into products and services. Services are anticipated to hold the larger revenue shares of the market and dominate the market segment in the upcoming five years in the account to surging demand for the efficient and effective treatment methods. Rapidly increasing cases of cardiovascular diseases, neurological diseases, renal failure, etc. are also substantiating the growth of the global organ-on-chip market in the future five years. Moreover, technological advancement in the medical devices is further substantiating the growth of the products sub-segment in the future five years. The sub-segment is expected to register significant growth in the next five years.

Based on type, the market is further bifurcated into liver, heart, lung, kidney, and others. Heart sub-segment is anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the account of increasing instances of cardiovascular diseases and surging demand from the patients opting for the advanced medical facilities. Rapidly increasing necessities in the research and development areas also aided the potential growth of the global organ-on-chip market in the future five years. Lung sub-segment is anticipated to register the fastest growing CAGR in the future five years on the account of surging demand for the same to overcome the damages caused due to SARS-CoV2 virus. The recent pandemic situation, experienced widespread COVID-19 virus that claimed many lives while affecting population’ cardiovascular system.

Market giants like Emulate, Inc., AxoSim Inc., Kirkstall Ltd., TissUse GmbH, Nortis Inc., Mimetas BV, Hurel Corporation, Ascendance Biotechnology, Inc., InSphero AG, CN Bio Innovations, Organovo Holdings, Inc., TARA Biosystems, Inc., BiomimX SRL, SynVivo, Inc., Hesperos, Inc., among others are holding major shares of the global organ-on-chip market. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through organ-on-chip. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7763

Customers can also request for 10% free customization on this report.

“North America is anticipated to emerge as the most promising region for the future market growth. The market growth is relied on the backbone of the advancing healthcare facility. Moreover, technological advancement and consistent research for the development of the microchips is further aiding the future growth of the market. New market players entering the market must focus on the development of the organ-on-chip devices that are more advanced and feasible to implant. Collaborations with the existent players and industry experts would aid their brand establishment,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Organ-on-Chip Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Type (Liver, Heart, Lung, Kidney, Others), By Offering (Products v/s Services), By Material Type (Polymer, PDMS, Glass, Silicon, Others), By Application (Physiological Model Development, Drug Discovery, Toxicological Research, Molecular Biology, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cosmetic Industry, Others), By Region”, has evaluated the future growth potential of global organ-on-chip and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global organ-on-chip market.

Browse Related Reports:

Global Hospital Acquired Infection Control Market By Product (Sterilizers, Disinfectors, Endoscope Re-processors, Others) By Application (Disease Testing, Drug-Resistance Testing) By Technology (Phenotypic Methods, Genotypic Methods) By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others) By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others) By Company, By Region, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/hospital-acquired-infection-control-market/7617.html

Global ELISA Test Market By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA) By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others (Infectious Diseases, Cancer, Protein Quantitation) By Technology (Chemiluminescent, Colorimetric, Fluorescent) By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others) By Company, By Region, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/elisa-test-market/7621.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Global Organ-on-Chip Market #Healthcare #Organ-on-Chip Market #Consumer Healthcare #Organ-on-Chip Market Size #Organ-on-Chip Market Forecast

0 notes

techscimarketresearch · 3 years

Text

Organ-on-Chip Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research

Increasing renal disease is driving the growth in Global Organ-on-chip Market in the forecast period, 2022-2026.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Organ-on-chip Market"

https://www.techsciresearch.com/report/organ-on-chip-market/7763.html

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7763

Customers can also request for 10% free customization on this report.

Browse Related Reports:

https://www.techsciresearch.com/report/hospital-acquired-infection-control-market/7617.html

https://www.techsciresearch.com/report/elisa-test-market/7621.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Global Organ-on-Chip Market #Healthcare #Consumer Healthcare #Organ-on-Chip Market #Organ-on-Chip Market Size #Organ-on-Chip Market Forecast

0 notes